Prostaglandin synthases: Recent developments and a novel hypothesis

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 70, Issue 2, 2004, Pages 101-113

  Helliwell, Rachel J A ^a   Adams, Linda F ^a,b   Mitchell, Murray D ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cyclooxygenase; Lipocalin; Parturition; Pregnancy; Prostaglandin D2; Prostaglandin synthase

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; 15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 20ALPHA HYDROXYSTEROID DEHYDROGENASE; CATALASE; CAVEOLIN 1; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPASE A2; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; PROSTAGLANDIN E; PROSTAGLANDIN E2; PROSTAGLANDIN F; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE; PROSTANOID; RETINOL BINDING PROTEIN; THROMBOXANE A2;

CARDIOVASCULAR DISEASE; CELL MEMBRANE; CELL STRUCTURE; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; NONHUMAN; OXYGEN SUPPLY; PLACENTA; PRECURSOR; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0942301255     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.04.002     Document Type: Article

References (178)

1. A. Metcalfe, C. Streuli, Epithelial Apoptosis Bioessays 19 (1997) 711-720.
2. R.S. Gilmour, M.D. Mitchell, Nuclear lipid signaling: novel role of eicosanoids, Exp. Biol. Med. (Maywood) 226 (2001) 1-4.
3. R. Negrel, Prostacyclin as a critical prostanoid in adipogenesis, Prostaglandins Leukot. Essent. Fatty Acids 60 (1999) 383-386.
4. J. Keelan, R. Helliwell, B. Nijmeijer, et al., 15-deoxy-delta12, 14-prostaglandin J2-induced apoptosis in amnion-like WISH cells, Prostaglandins Other Lipid Mediat. 66 (2001) 265-282.
5. J.A. Keelan, T.A. Sato, K.W. Marvin, J. Lander, R.S. Gilmour, M.D. Mitchell, 15-Deoxy-delta(12,14)-prostaglandin J(2) a ligand for peroxisome proliferator-activated receptor-gamma induces apoptosis in JEG3 choriocarcinoma cells, Biochem. Biophys. Res. Commun. 262 (1999) 579-585.
6. M.D. Mitchell, Biochemistry of the prostaglandins, Bailliere Clin. Obstet. Gynaecol. 6 (1992) 687-706.
7. W.R. Hansen, J.A. Keelan, S.J. Skinner, M.D. Mitchell, Key enzymes of prostaglandin biosynthesis and metabolism Coordinate regulation of expression by cytokines in gestational tissues: a review, Prostaglandins Other Lipid. Mediat. 57 (1999) 243-257.
8. S.T. Holgate, O.P. Twentyman, P. Rafferty, et al., Primary and secondary effector cells in the pathogenesis of bronchial asthma, Int. Arch. Allergy Appl. Immunol. 82 (1987) 498-506.
9. M. Fukushima, Prostaglandin J2 - anti-tumour and anti-viral activities and the mechanisms involved [published erratum appears in Eicosanoids 4(2) (1991) 119], Eicosanoids 3 (1990) 189-199.
10. M. Fukushima, Biological activities and mechanisms of action of PGJ2 and related compounds: an update, Prostaglandins Leukot. Essent. Fatty Acids 47 (1992) 1-12.
11. D. Bishop-Bailey, S. Calatayud, T.D. Warner, T. HIa, J.A. Mitchell, Prostaglandins and the regulation of tumor growth, J. Environ. Pathol. Toxicol. Oncol. 21 (2002) 93-101.
12. M. Reilly, G.A. Fitzgerald, Cellular activation by thromboxane A2 and other eicosanoids, Eur. Heart J. 14 (Suppl K) (1993) 88-93.
13. J.L. Mills, R. DerSimonian, E. Raymond, et al., Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study, JAMA 282 (1999) 356-362.
14. S.W. Walsh, Preeclampsia: an imbalance in placental prostacyclin and thromboxane production, Am. J. Obstet. Gynecol. 152 (1985) 335-340.
15. F. Petraglia, L. Aguzzoli, A. Gallinelli, et al., Hypertension in pregnancy: changes in activin A maternal serum concentration, Placenta 16 (1995) 447-454.
16. L. Myatt, M. Miodovnik, Prediction of preeclampsia, Semin. Perinatol. 23 (1999) 45-57.
17. M. Blumenstein, J.A. Keelan, M.D. Mitchell, Hypoxia attenuates PGE(2)but increases prostacyclin and thromboxane production in human term villous trophoblast, Placenta 22 (2001) 519-525.
18. J.E. Brian Jr., S.A. Moore, F.M. Faraci, Expression and vascular effects of cyclooxygenase-2 in brain, Stroke 29 (1998) 2600-2606.
19. G. Haugen, I. Helland, Influence of preeclampsia or maternal intake of omega-3 fatty acids on the vasoactive effect of prostaglandin F-two-alpha in human umbilical arteries, Gynecol. Obstet. Invest. 52 (2001) 75-81.
20. E.J. Oliveira, M.A. Romero, M.S. Silva, B.A. Silva, I.A. Medeiros, Intracellular calcium mobilization as a target for the spasmolytic action of scopoletin, Planta. Med. 67 (2001) 605-608.
21. O. Hayaishi, H. Matsumura, Prostaglandins and sleep, Adv. Neuroimmunol. 5 (1995) 211-216.
22. B.M. Forman, P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, R.M. Evans, 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma, Cell 83 (1995) 803-812.
23. D.S. Straus, G. Pascual, M. Li, et al., 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway, Proc. Natl. Acad. Sci. USA 97 (2000) 4844-4849.
24. T. Koizumi, M. Negishi, A. Ichikawa, Inhibitory effect of an intracellular glutathione on delta 12-prostaglandin J2-induced protein syntheses in porcine aortic endothelial cells, Biochem. Pharmacol. 44 (1992) 1597-1602.
25. M.J. Reginato, S.L. Krakow, S.T. Bailey, M.A. Lazar, Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma, J. Biol. Chem. 273 (1998) 1855-1858.
26. D.W. Gilroy, P.R. Colville-Nash, D. Willis, J. Chivers, M.J. Paul-Clark, D.A. Willoughby, Inducible cyclooxygenase may have anti-inflammatory properties, Nat. Med. 5 (1999) 698-701.
27. T. Tanioka, Y. Nakatani, N. Semmyo, M. Murakami, I. Kudo, Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis, J. Biol. Chem. 275 (2000) 32775-32782.
28. P.J. Jakobsson, S. Thoren, R. Morgenstern, B. Samuelsson, Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target, Proc. Natl. Acad. Sci. USA 96 (1999) 7220-7225.
29. L. Forsberg, L. Leeb, S. Thoren, R. Morgenstern, P. Jakobsson, Human glutathione dependent prostaglandin E synthase: gene structure and regulation, FEBS Lett. 471 (2000) 78-82.
30. M. Murakami, H. Naraba, T. Tanioka, et al., Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2, J. Biol. Chem. 275 (2000) 32783-32792.
31. Y. Kanaoka, K. Fujimori, R. Kikuno, Y. Sakaguchi, Y. Urade, O. Hayaishi, Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase, Eur. J. Biochem. 267 (2000) 3315-3322.
32. P.J. Jakobsson, R. Morgenstern, J. Mancini, A. Ford-Hutchinson, B. Persson, Common structural features of MAPEG - a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism, Protein Sci. 8 (1999) 689-692.
33. D.O. Stichtenoth, S. Thoren, H. Bian, M. Peters-Golden, P.J. Jakobsson, L.J. Crofford, Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells, J. Immunol. 167 (2001) 469-474.
34. S. Uematsu, M. Matsumoto, K. Takeda, S. Akira, Lipopolysaccharide- dependent prostaglandin E(2) production is regulated by the glutathione- dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway, J. Immunol. 168 (2002) 5811-5816.
35. F. Kojima, H. Naraba, Y. Sasaki, R. Okamoto, T. Koshino, S. Kawai, Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells, J. Rheumatol. 29 (2002) 1836-1842.
36. Y. Devaux, C. Seguin, S. Grosjean, et al., Lipopolysaccharide-induced increase of prostaglandin E(2) is mediated by inducible nitric oxide synthase activation of the constitutive cyclooxygenase and induction of membrane-associated prostaglandin E synthase, J. Immunol. 167 (2001) 3962-3971.
37. H. Naraba, C. Yokoyama, N. Tago, et al., Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1, J. Biol. Chem. 277 (2002) 28601-28608.
38. J.A. Mancini, K. Blood, J. Guay, et al., Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis, J. Biol. Chem. 276 (2001) 4469-4475.
39. S. Thoren, P.J. Jakobsson, Coordinate up-and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4, Eur. J. Biochem. 267 (2000) 6428-6434.
40. N. Tanikawa, Y. Ohmiya, H. Ohkubo, et al., Identification and characterization of a novel type of membrane-associated prostaglandin E synthase, Biochem. Biophys. Res. Commun. 291 (2002) 884-889.
41. F. Filion, N. Bouchard, A.K. Goff, J.G. Lussier, J. Sirois, Molecular cloning and induction of bovine prostaglandin E synthase by gonadotropins in ovarian follicles prior to ovulation in vivo, J. Biol. Chem. 276 (2001) 34323-34330.
42. B.J. Davis, D.E. Lennard, C.A. Lee, et al., Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta, Endocrinology 140 (1999) 2685-2695.
43. H. Ni, T. Sun, X.H. Ma, Z.M. Yang, Expression and regulation of cytosolic prostaglandin E synthase in mouse uterus during the peri-implantation period, Biol. Reprod. 68 (2003) 744-750.
44. F.J. Teixeira, T. Zakar, J. Hirst, F. Guo, G. Machin, D.M. Olson, Prostaglandin endoperoxide H synthase (PGHS) activity increases with gestation and labour in human amnion, J. Lipid. Mediat. 6 (1993) 515-523.
45. F.J. Teixeira, T. Zakar, J.J. Hirst, et al., Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor, J. Clin. Endocrinol. Metab. 78 (1994) 1396-1402.
46. M.D. Mitchell, R.J. Romero, S.S. Edwin, M.S. Trautman, Prostaglandins and parturition, Reprod. Fertil. Dev. 7 (1995) 623-632.
47. Y. Sadovsky, D.M. Nelson, L.J. Muglia, et al., Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2, Am. J. Obstet. Gynecol. 182 (2000) 370-376.
48. W. Gibb, R.L. Martin, W.L. Whittle, et al., Ontogeny and regulation of ovine placental prostaglandin E2 synthase, J. Soc. Gynecol. Invest. 9 (2002) 212A.
49. K.W. Marvin, B. Parks, K. Ja, T.A. Sato, M.D. Mitchell, Expression of microsomal prostaglandin E synthase in human gestational tissues with labor at term and with infection and labour preterm, J. Soc. Gynecol. Invest. 9 (2002) 212A.
50. J.M. Meadows, A. Eis, D.E. Brockman, L. Myatt, Expression and localization of cytosolic prostaglandin E synthase (p23) in human amnion and chorion tissues, J. Soc. Gynecol. Invest. 9 (2002) 213A.
51. J.M. Meadows, A. Eis, D.E. Brockman, L. Myatt, Expression and localization of membrane-bound prostaglandin E synthase in human amnion and chorion, J. Soc. Gynecol. Invest. 9 (2002) 212A.
52. D. Slater, S. Astle, S. Thornton, Expression of inducible prostaglandin E synthase in human gestational tissues, J. Soc. Gynecol. Invest. 9 (2002) 211A.
53. J.W. Meadows, A.L. Eis, D.E. Brockman, L. Myatt, Expression and localization of prostaglandin E synthase isoforms in human fetal membranes in term and preterm labor, J. Clin. Endocrinol. Metab. 88 (2003) 433-439.
54. N. Alfaidy, M. Sun, J. Challis, W. Gibb, Expression of membrane prostaglandin E synthase in human placenta and fetal membranes and effect of labor, Endocrine 20 (2003) 219-226.
55. J. Senior, K. Marshall, R. Sangha, J.K. Clayton, In vitro characterization of prostanoid receptors on human myometrium at term pregnancy, Br. J. Pharmacol. 108 (1993) 501-506.
56. D.J. Crankshaw, V. Gaspar, Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes, J. Reprod. Fertil. 103 (1995) 55-61.
57. J.L. Cook, D.B. Zaragoza, D.H. Sung, D.M. Olson, Expression of myometrial activation and stimulation genes in a mouse model of preterm labor: myometrial activation stimulation and preterm labor, Endocrinology 141 (2000) 1718-1728.
58. J.R. Challis, D.M. Sloboda, N. Alfaidy, et al., Prostaglandins and mechanisms of preterm birth, Reproduction 124 (2002) 1-17.
59. T.L. Erkinheimo, K. Saukkonen, K. Narko, J. Jalkanen, O. Ylikorkala, A. Ristimaki, Expression of cyclooxygenase-2 and prostanoid receptors by human myometrium, J. Clin. Endocrinol. Metab. 85 (2000) 3468-3475.
60. D.M. Slater, S. Zervou, S. Thornton, Prostaglandins and prostanoid receptors in human pregnancy and parturition, J. Soc. Gynecol. Invest. 9 (2002) 118-124.
61. H. Lan, K. Blake-Palmer, M.D. Mitchell, R.J.A. Helliwell, Identification and localization of prostaglandin E2 receptor (EP2) in human gestational tissues, J. Soc. Gynecol. Invest. 10 (2003) 148A.
62. R.J.A. Helliwell, K. Blake-Palmer, H. Lan, M.D. Mitchell, Expression of prostaglandin receptor isoforms in human gestational tissues, J. Soc. Gynecol. Invest. 10 (2003) 148A.
63. E. Unlugedik, N. Alfaidy, W. Li, J.R.G. Challis, Expression of prostaglandin receptors in purified cell preparations from the human placenta and fetal membranes and the effect of labor, J. Soc. Gynecol. Invest. 10 (2003) 147A.
64. J. McLaren, D.J. Taylor, S.C. Bell, Prostaglandin E(2)-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes, Mol. Hum. Reprod. 6 (2000) 1033-1040.
65. N. Athayde, R. Romero, R. Gomez, et al., Matrix metalloproteinases-9 in preterm and term human parturition, J. Matern. - Fetal Med. 8 (1999) 213-219.
66. G.D. Bryant-Greenwood, The extracellular matrix of the human fetal membranes: structure and function, Placenta 19 (1998) 1-11.
67. K. Watanabe, Prostaglandin F synthase, Prostaglandins Other Lipid. Mediat. 68-69 (2002) 401-407.
68. K. Watanabe, R. Yoshida, T. Shimizu, O. Hayaishi, Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung, J. Biol. Chem. 260 (1985) 7035-7041.
69. T. Suzuki-Yamamoto, M. Nishizawa, M. Fukui, et al., cDNA cloning, expression and characterization of human prostaglandin F synthase, FEBS Lett. 462 (1999) 335-340.
70. L.Y. Chen, K. Watanabe, O. Hayaishi, Purification and characterization of prostaglandin F synthase from bovine liver, Arch. Biochem. Biophys. 296 (1992) 17-26.
71. T. Suzuki, Y. Fujii, M. Miyano, L.Y. Chen, T. Takahashi, K. Watanabe, cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase, J. Biol. Chem. 274 (1999) 241-248.
72. T. Suzuki-Yamamoto, K. Toida, Y. Tsuruo, K. Watanabe, K. Ishimura, Immunocytochemical localization of lung-type prostaglandin F synthase in the rat spinal cord. Brain Res. 877 (2000) 391-395.
73. S. Palea, G. Toson, C. Pietra, et al., Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder, Br. J. Pharmacol. 124 (1998) 865-872.
74. K.G. Peri, C. Quiniou, X. Hou, et al., THG113: a novel selective FP antagonist that delays preterm labor, Semin. Perinatol. 26 (2002) 389-397.
75. J.C.T. Stier, I.L.J. Roberts, P.Y. Wong, (5Z,13E)-(15S)-9Alpha 11beta, 15-trihydroxyprosta-5, 13-dien-1-oic acid (9 alpha 11 beta-prostaglandin F2): formation and metabolism by human lung and contractile effects on human bronchial smooth muscle, Proc. Natl. Acad. Sci. 84 (1987) 256-260.
76. C.T. Stier Jr., L.J. Roberts II, P.Y. Wong, Renal response to 9 alpha, 11 beta-prostaglandin F2 in the rat, J. Pharmacol. Exp. Ther. 243 (1987) 487-491.
77. T.E. Liston, L.J. Roberts II, Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans, Proc. Natl. Acad. Sci. USA 82 (1985) 6030-6034.
78. N. Wintergalen, H.H. Thole, H.J. Galla, W. Schlegel, Prostaglandin-E2 9-reductase from corpus luteum of pseudopregnant rabbit is a member of the aldo-keto reductase superfamily featuring 20 alpha-hydroxysteroid dehydrogenase activity, Eur. J. Biochem. 234 (1995) 264-270.
79. K. Watanabe, Y. Fujii, K. Nakayama, et al., Structural similarity of bovine lung prostaglandin F synthase to lens epsilon-crystallin of the European common frog, Proc. Natl. Acad. Sci. USA 85 (1988) 11-15.
80. Y.F. Wang, Y.C. Jin, Y.E. Wu, L.J. Gu, X.H. Xie, The cervix-ripening effect of 15-methyl-prostaglandin F2 alpha methyl ester before vacuum aspiration for termination of early pregnancy in primigravidae, Chin Med. J. (Engl.) 102 (1989) 200-202.
81. M. Yoshida, N. Sagawa, H. Itoh, et al., Prostaglandin F(2alpha), cytokines and cyclic mechanical stretch augment matrix metalloproteinase-1 secretion from cultured human uterine cervical fibroblast cells, Mol. Hum. Reprod. 8 (2002) 681-687.
82. W.X. Wu, X.H. Ma, T. Yoshizato, N. Shinozuka, P.W. Nathanielsz, Increase in prostaglandin H synthase 2 but not prostaglandin F2alpha synthase mRNA in intrauterine tissues during betamethasone-induced premature labor and spontaneous term labor in sheep, J. Soc. Gynecol. Invest. 8 (2001) 69-76.
83. E. Madore, N. Harvey, J. Parent, P. Chapdelaine, J.A. Arosh, M.A. Fortier, An aldose reductase with 20alpha - hydroxysteroid dehydrogenase activity is most likely the enzyme responsible for the production of prostaglandin F2alpha in the bovine endometrium, J. Biol. Chem. 278 (2003) 11205-11212.
84. M. Nishizawa, T. Nakajima, K. Yasuda, et al., Close kinship of human 20alpha-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes, Genes Cells 5 (2000) 111-125.
85. S. Hara, A. Miyata, C. Yokoyama, et al., Molecular cloning and expression of prostacyclin synthase from endothelial cells, Adv. Prostag. Thromb. Leukot. Res. 23 (1995) 121-123.
86. C. Yokoyama, A. Miyata, H. Ihara, V. Ullrich, T. Tanabe, Molecular cloning of human platelet thromboxane A synthase, Biochem. Biophys. Res. Commun. 178 (1991) 1479-1484.
87. K. Ohashi, K.H. Ruan, R.J. Kulmacz, K.K. Wu, L.H. Wang, Primary structure of human thromboxane synthase determined from the cDNA sequence, J. Biol. Chem. 267 (1992) 789-793.
88. R.F. Shen, H.H. Tai, Thromboxanes: synthase and receptors, J. Biomed. Sci. 5 (1998) 153-172.
89. T. Tanabe, V. Ullrich, Prostacyclin and thromboxane synthases, J. Lipid. Mediat. Cell Signal. 12 (1995) 243-255.
90. E.L. Schiffrin, A critical review of the role of endothelial factors in the pathogenesis of hypertension, J. Cardiovasc. Pharmacol. 38 (Suppl 2) (2001) S3-6.
91. K. Yusuf, S.D. Smith, R. Levy, et al., Thromboxane A(2) limits differentiation and enhances apoptosis of cultured human trophoblasts, Pediatr. Res. 50 (2001) 203-209.
92. A. Miyata, C. Yokoyama, H. Ihara, et al., Characterization of the human gene (TBXAS1) encoding thromboxane synthase, Eur. J. Biochem. 224 (1994) 273-279.
93. K.D. Lee, S.J. Baek, R.F. Shen, Cloning and characterization of the human thromboxane synthase gene promoter, Biochem. Biophys. Res. Commun. 201 (1994) 379-387.
94. H. Ihara, C. Yokoyama, A. Miyata, et al., Induction of thromboxane synthase and prostaglandin endoperoxide synthase mRNAs in human erythroleukemia cells by phorbol ester, FEBS Lett. 306 (1992) 161-164.
95. R. Nusing, V. Ullrich, Regulation of cyclooxygenase and thromboxane synthase in human monocytes, Eur. J. Biochem. 206 (1992) 131-136.
96. T. Nanayama, S. Hara, H. Inoue, C. Yokoyama, T. Tanabe, Regulation of two isozymes of prostaglandin endoperoxide synthase and thromboxane synthase in human monoblastoid cell line U937, Prostaglandins 49 (1995) 371-382.
97. I. Siegle, T. Klein, M.H. Zou, P. Fritz, M. Komhoff, Distribution and cellular localization of prostacyclin synthase in human brain, J. Histochem. Cytochem. 48 (2000) 631-641.
98. J.Y. Liou, S.K. Shyue, M.J. Tsai, C.L. Chung, K.Y. Chu, K.K. Wu, Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells, J. Biol. Chem. 275 (2000) 15314-15320.
99. D. Korita, N. Sagawa, H. Itoh, et al., Cyclic mechanical stretch augments prostacyclin production in cultured human uterine myometrial cells from pregnant women: possible involvement of up-regulation of prostacyclin synthase expression, J. Clin. Endocrinol. Metab. 87 (2002) 5209-5219.
100. M. Murakami, I. Kudo, K. Inoue, Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2, J. Biol. Chem. 268 (1993) 839-844.
101. S. Hara, A. Miyata, C. Yokoyama, et al., Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells, J. Biol. Chem. 269 (1994) 19897-19903.
102. S. Fleisher-Berkovich, A. Danon, IL-1alpha but not IL-1beta-induced prostaglandin synthesis is inhibited by corticotropin-releasing factor, Cytokine 11 (1999) 239-243.
103. A. Miyata, S. Hara, C. Yokoyama, H. Inoue, V. Ullrich, T. Tanabe, Molecular Cloning and Expression of Human Prostacyclin Synthase, Biochem. Biophys. Res. Commun. 200 (1994) 1728-1734.
104. D. Chevalier, C. Cauffiez, C. Bernard, et al., Characterization of new mutations in the coding sequence and 5′-untranslated region of the human prostacyclin synthase gene (CYP8A1), Hum. Genet. 108 (2001) 148-155.
105. H.L. Rupnow, T.M. Phernetton, M.L. Modrick, M.C. Wiltbank, I.M. Bird, R.R. Magness, Endothelial vasodilator production by uterine and systemic arteries. VIII. Estrogen and progesterone effects on cPLA2, COX-1 and PGIS protein expression, Biol. Reprod. 66 (2002) 468-474.
106. J. Rowe, S. Campbell, E.D. Gallery, Effects of hypoxia on regulation of prostanoid production in decidual endothelial cells in normal and preeclamptic pregnancy, J. Soc. Gynecol. Invest. 7 (2000) 118-124.
107. C.S. Shellhaas, T. Coffman, P.J. Dargie, A.P. Killam, H.H. Kay, Intravillous eicosanoid compartmentalization and regulation of placental blood flow, J. Soc. Gynecol. Invest. 4 (1997) 58-63.
108. W.X. Wu, X.H. Ma, P.W. Nathanielsz, Changes in prostacyclin synthase in pregnant sheep myometrium, endometrium, and placenta at spontaneous term labor and regulation by estradiol and progesterone, Am. J. Obstet. Gynecol. 180 (1999) 744-749.
109. D. Giannoulias, N. Alfaidy, A.C. Holloway, et al., Expression of prostaglandin I(2) synthase, but not prostaglandin E synthase, changes in myometrium of women at term pregnancy, J. Clin. Endocrinol. Metab. 87 (2002) 5274-5282.
110. R. Doroudi, L.M. Gan, L. Selin Sjogren, S. Jern, Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model, Biochem. Biophys. Res. Commun. 269 (2000) 257-264.
111. Y. Urade, O. Hayaishi, Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase, Biochim. Biophys. Acta 1482 (2000) 259-271.
112. K. Fujimori, Y. Kanaoka, Y. Sakaguchi, Y. Urade, Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the oct-1 element in the 5′-flanking region and the AP-2 element in the untranslated exon 1, J. Biol. Chem. 275 (2000) 40511-40516.
113. L.F. Garcia-Fernandez, Y. Urade, O. Hayaishi, J. Bernal, A. Munoz, Identification of a thyroid hormone response element in the promoter region of the rat lipocalin-type prostaglandin D synthase (beta-trace) gene, Brain Res. Mol. Brain Res. 55 (1998) 321-330.
114. M. Otsuki, H. Gao, K. Dahlman-Wright, et al., Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor {beta}, Mol. Endocrinol. 17 (9) (2003) 1844-1855.
115. L.F. Garcia-Fernandez, M.A. Iniguez, N. Eguchi, M. Fresno, Y. Urade, A. Munoz, Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells, J. Neurochem. 75 (2000) 460-470.
116. K. Fujimori, Y. Fujitani, K. Kadoyama, H. Kumanogoh, K. Ishikawa, Y. Urade, Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1 beta via two NF-kappa B elements in rat leptomeningeal cells, J. Biol. Chem. 278 (2003) 6018-6026.
117. Y. Taba, T. Sasaguri, M. Miyagi, et al., Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells, Circ. Res. 86 (2000) 967-973.
118. L. Saso, G. Valentini, M.G. Leone, et al., Changes in concanavalin A-reactive proteins in neurological disorders, J. Clin. Lab. Anal. 13 (1999) 158-165.
119. S. Grunewald, K. Huyben, J.G. de Jong, et al., Beta-trace protein in human cerebrospinal fluid: a diagnostic marker for N-glycosylation defects in brain, Biochim. Biophys. Acta 1455 (1999) 54-60.
120. H. Manya, Y. Sato, N. Eguchi, et al., Comparative study of the asparagine-linked sugar chains of human lipocalin-type prostaglandin D synthase purified from urine and amniotic fluid, and recombinantly expressed in Chinese hamster ovary cells, J. Biochem. (Tokyo) 127 (2000) 1001-1011.
121. R. Baeker, S. Haebel, K. Schlatterer, B. Schlatterer, Lipocalin-type prostaglandin D synthase in milk: a new biomarker for bovine mastitis, Prostaglandins Other Lipid. Mediat. 67 (2002) 75-88.
122. F. Angenstein, K. Buchner, S. Staak, Age-dependent differences in glutamate-induced phosphorylation systems in rat hippocampal slices, Hippocampus 9 (1999) 173-185.
123. N. Ueno, M. Murakami, T. Tanioka, et al., Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2, J. Biol. Chem. 276 (2001) 34918-34927.
124. O. Hayaishi, Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2, Philos. Trans. R. Soc. Lond. B Biol. Sci. 355 (2000) 275-280.
125. T. Minami, E. Okuda-Ashitaka, M. Nishizawa, H. Mori, S. Ito, Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2, Br. J. Pharmacol. 122 (1997) 605-610.
126. N. Eguchi, T. Minami, N. Shirafuji, et al., Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice, Proc. Natl. Acad. Sci. USA 96 (1999) 726-730.
127. B. Cooper, Diminished platelet adenylate cyclase activation by prostaglandin D2 in acute thrombosis, Blood 54 (1979) 684-693.
128. D.S. VanderEnde, J.D. Morrow, Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans after the application of cinnamic aldehyde, J. Am. Acad. Dermatol. 45 (2001) 62-67.
129. L. Walch, C. Labat, J.P. Gascard, V. de Montpreville, C. Brink, X. Norel, Prostanoid receptors involved in the relaxation of human pulmonary vessels, Br. J. Pharmacol. 126 (1999) 859-866.
130. S.L. Johnston, N.J. Freezer, W. Ritter, S. O'Toole, P.H. Howarth, Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor, Eur. Respir. J. 8 (1995) 411-415.
131. F. Ushikubi, Y. Sugimoto, A. Ichikawa, S. Narumiya, Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors, Jpn. J. Pharmacol. 83 (2000) 279-285.
132. A. Arimura, K. Yasui, J. Kishino, et al., Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751, J. Pharmacol. Exp. Ther. 298 (2001) 411-419.
133. M.D. Mitchell, D.L. Kraemer, D.M. Strickland, The human placenta: a major source of prostaglandin D2, Prostaglandins Leukot. Med. 8 (1982) 383-387.
134. E.R. Norwitz, P.M. Starkey, A. Lopez Bernal, Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry, Obstet. Gynecol. 80 (1992) 440-445.
135. T. Michimata, H. Tsuda, M. Sakai, et al., Accumulation of CRTH2-positive T-helper 2 and T-cytotoxic 2 cells at implantation sites of human decidua in a prostaglandin D(2)-mediated manner, Mol. Hum. Reprod. 8 (2002) 181-187.
136. K.W. Marvin, J.A. Keelan, S. O'Carroll, R.J. Romero, T. Chaiworapongsa, M.D. Mitchell, Distribution and relationship to labor at term or preterm of prostaglandin(PG) D synthases and amniotic fluid concentrations of PGD2 and 15-deoxy-delta-12,14 PGJ2, J. Soc. Gynecol. Invest. 9 (2002) 212A.
137. F.A. Fitzpatrick, M.A. Wynalda, Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro, J. Biol. Chem. 258 (1983) 11713-11718.
138. T. Shibata, M. Kondo, T. Osawa, N. Shibata, M. Kobayashi, K. Uchida, 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes, J. Biol. Chem. 277 (2002) 10459-10466.
139. H. Ma, H.W. Sprecher, P.E. Kolattukudy, Estrogen-induced production of a peroxisome proliferator-activated receptor (PPAR) ligand in a PPARgamma-expressing tissue, J. Biol. Chem. 273 (1998) 30131-30138.
140. Y. Boie, N. Sawyer, D.M. Slipetz, K.M. Metters, M. Abramovitz, Molecular cloning and characterization of the human prostanoid DP receptor, J. Biol. Chem. 270 (1995) 18910-18916.
141. M. Kiriyama, F. Ushikubi, T. Kobayashi, M. Hirata, Y. Sugimoto, S. Narumiya, Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells, Br. J. Pharmacol. 122 (1997) 217-224.
142. H. Hirai, K. Tanaka, O. Yoshie, et al., Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells eosinophils and basophils via seven-transmembrane receptor CRTH2, J. Exp. Med. 193 (2001) 255-261.
143. N. Sawyer, E. Cauchon, A. Chateauneuf, et al., Molecular pharmacology of the human prostaglandin D(2) receptor, CRTH2, Br. J. Pharmacol. 137 (2002) 1163-1172.
144. S.A. Kliewer, J.M. Lenhard, T.M. Willson, I. Patel, D.C. Morris, J.M. Lehmann, A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation, Cell 83 (1995) 813-819.
145. T.V. Petrova, K.T. Akama, L.J. Van Eldik, Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12, 14-prostaglandin J2, Proc. Natl. Acad. Sci. USA 96 (1999) 4668-4673.
146. W.T. Schaiff, M.G. Carlson, S.D. Smith, R. Levy, D.M. Nelson, Y. Sadovsky, Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner, J. Clin. Endocrinol. Metab. 85 (2000) 3874-3881.
147. B. Fernandes, D. Crankshaw, Functional characterization of the prostanoid DP receptor in human myometrium, Eur. J. Pharmacol. 283 (1995) 73-81.
148. H. Abe, T. Takeshita, K. Nagata, et al., Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family, Gene 227 (1999) 71-77.
149. R.D. Hunziker, T.G. Wegmann, Placental immunoregulation, Crit. Rev. Immunol. 6 (1986) 245-285.
150. H. Tsuda, T. Michimata, M. Sakai, K. Nagata, M. Nakamura, S. Saito, A novel surface molecule of Th2-and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4+ and CD8+ T cells during the early stage of pregnancy, Clin. Exp. Immunol. 123 (2001) 105-111.
151. T. Suzuki-Yamamoto, H. Yokoi, Y. Tsuruo, K. Watanabe, K. Ishimura, Identification of prostaglandin F-producing cells in the liver, Histochem. Cell. Biol. 112 (1999) 451-456.
152. H. Giles, M.L. Bolofo, S.J. Lydford, G.R. Martin, A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2, Br. J. Pharmacol. 104 (1991) 541-549.
153. L. Li, J. Tao, J. Davaille, et al., 15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors, J. Biol. Chem. 276 (2001) 38152-38158.
154. H. Lei, E.E. Furth, R. Kalluri, et al., A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor, J. Clin. Invest. 98 (1996) 1971-1978.
155. O.C. Trifan, R.M. Smith, B.D. Thompson, T. Hla, Over-expression of cyclooxygenase-2 induces cell cycle arrest Evidence for a prostaglandin- independent mechanism, J. Biol. Chem. 274 (1999) 34141-34147.
156. H. Parfenova, V.N. Parfenov, B.V. Shlopov, et al., Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells, Am. J. Physiol. Cell Physiol. 281 (2001) C166-178.
157. C.T. Beuckmann, Y. Urade, O. Hayaishi, Lipocalin-type prostaglandin D synthase (beta-trace) binds non-substrate lipophilic ligands, Adv. Exp. Med. Biol. 469 (1999) 55-60.
158. D.R. Flower, The lipocalin protein family: structure and function, Biochem. J. 318 (1996) 1-14.
159. D.R. Flower, The lipocalin protein family: a role in cell regulation, FEBS Lett. 354 (1994) 7-11.
160. J.K. Maesaka, T. Palaia, L. Frese, S. Fishbane, L. Ragolia, Prostaglandin D(2) synthase induces apoptosis in pig kidney LLC-PK1 cells, Kidney Nit. 60 (2001) 1692-1698.
161. L. Ragolia, T. Palaia, L. Frese, S. Fishbane, J.K. Maesaka, Prostaglandin D2 synthase induces apoptosis in PC12 neuronal cells, Neuroreport 12 (2001) 2623-2628.
162. D.R. Flower, Beyond the superfamily: the lipocalin receptors, Biochim. Biophys. Acta 1482 (2000) 327-336.
163. P. Wojnar, M. Lechner, P. Merschak, B. Redl, Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display, J. Biol. Chem. 276 (2001) 20206-20212.
164. C.T. Beuckmann, M. Lazarus, D. Gerashchenko, et al., Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat, J. Comp. Neurol. 428 (2000) 62-78.
165. N.R. Thotakura, L. LiCalzi, B.D. Weintraub, The role of carbohydrate in thyrotropin action assessed by a novel approach using enzymatic deglycosylation,
166. K.W. Marvin, R.L. Eykholt, M.D. Mitchell, Subcellular localization of prostaglandin H synthase-2 in a human amnion cell line: implications for nuclear localized prostaglandin signaling pathways, Prostaglandins Leukot. Essent. Fatty Acids 62 (2000) 7-11.
167. R. Han, T.J. Smith, Cytoplasmic prostaglandin E2 synthase is dominantly expressed in cultured KAT-50 thyrocytes cells that express constitutive prostaglandin-endoperoxide H synthase-2 Basis for low protaglandin E2 production, J. Biol. Chem. 277 (2002) 36897-36903.
168. J.Y. Liou, W.G. Deng, D.W. Gilroy, S.K. Shyue, K.K. Wu, Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts, J. Biol. Chem. 276 (2001) 34975-34982.
169. E. Spisni, C. Griffoni, S. Santi, et al., Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis, Exp. Cell Res. 266 (2001) 31-43.
170. M.L. Massimino, C. Griffoni, E. Spisni, M. Toni, V. Tomasi, Involvement of caveolae and caveolae-like domains in signalling, cell survival and angiogenesis, Cell Signal. 14 (2002) 93-98.
171. J. Couet, M. Sargiacomo, M.P. Lisanti, Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities, J. Biol. Chem. 272 (1997) 30429-30438.
172. J. Couet, S. Li, T. Okamoto, T. Ikezu, M.P. Lisanti, Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins, J. Biol. Chem. 272 (1997) 6525-6533.
173. L. Saso, M.G. Leone, C. Sorrentino, et al., Quantification of prostaglandin D synthetase in cerebrospinal fluid: a potential marker for brain tumor, Biochem. Mol. Biol. Int. 46 (1998) 643-656.
174. M. Mase, K. Yamada, A. Iwata, et al., Acute and transient increase of lipocalin-type prostaglandin D synthase (beta-trace) level in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage, Neurosci. Lett. 270 (1999) 188-190.
175. H.H. Rasmussen, T.F. Orntoft, H. Wolf, J.E. Celis, Towards a comprehensive database of proteins from the urine of patients with bladder cancer, J. Urol. 155 (1996) 2113-2119.
176. G.H. Borchert, D.N. Melegos, H. Yu, et al., Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification, Clin. Biochem. 32 (1999) 39-44.
177. R.J.A. Helliwell, E.B.E. Berry, S.J. O'Carroll, M.D. Mitchell, Nuclear prostaglandin receptors: role in pregnancy and parturition? Prostaglandins Leukot. Essent. Fatty Acids, this issue, 2003, doi:10.1016/j.plefa.2003.04.005.
178. L. Myatta, S.J. Lyeb, Expression, localization and function of prostaglandin receptors in myometrium, Prostaglandin Leukot. Essent. Fatty Acids, this issue, 2003, doi:10.1016/ j.plefa.2003.04.004.